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SUMMARY
Of eighty-three tumours of ependymal origin diagnosed in the twenty years
1969-1988 in Northern Ireland, fifteen were located within the spine. Two were
in children, 13 in young adults with a mean age of 33 years. 70% presented
with back pain and 60% had weakness of the lower limbs. Survival was found
to correlate well with histological grading (WHO classification). The mean time
of survival for tumours graded 1/2 was six years; there were three long-term
survivors of 13, 1 7 and 18 years; 90% of the patients survived 2-5 years.
INTRODUCTION
Ependymomas arise from the cells lining the cerebral ventricles and the central
canal of the spinal cord. There is a very wide variation in the proportion of
cases reported as arising from the spinal cord. In most series, the vast majority
of ependymomas arise within the cranial cavity, especially in children, and only
a small proportion are of spinal origin. Clinicopathological series with large
numbers of patients usually emanate from tertiary referral centres and therefore
may not reflect the true geographical distribution of these tumours in a defined
population. The Departments of Neurological Surgery and Neuropathology atthe
Royal Victoria Hospital, Belfast provide the regional services for the 1-5 million
population of Northern Ireland, so that all cases diagnosed as ependymoma will
pass through one or both of these departments.
MATERIALS AND METHODS
The frequency of occurrence of spinal cord ependymomas from 1 January 1969
to 31 December 1988 was found from the records of both departments. There
were 83 tumours of ependymal origin of which 15 (18%) were in the spinal cord.
Theclinical and neuropathological material presented istaken from those patients
whose diagnosis was confirmed as spinal cord ependymoma on histopathological
review. Operative death was defined as occurring within 30 days of a surgical
procedure. Follow-up was determined up to 31 December 1988, in some
instances by contact with the patients' general practitioner.
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RESULTS
There were 15 ependymomas of the spinal cord or cauda equina. Age at
diagnosis ranged from 5 to 58 years, mean 33 years. Only two children were
identified, aged 5 and 13 years. There were nine male and six female patients,
male/female ratio 1 *5: 1.
The commonest complaints were low back pain in 11 (73%), and weakness of
the lower limbs in five (33%). On examination nine (60%) had lower limb
weakness. A long delay from symptom onset to establishment of the true
diagnosis was not uncommon, varying from one month to 12 years (mean 2 5
years).
Myelography was the principal diagnostic investigation, in recent years replaced
by computerised tomography with myelographic enhancement (CT myelogram).
In all cases decompressive laminectomy was performed, total removal of the
tumour being achieved in six patients (40%). In one instance, only a tumour
biopsy was possible and this patient died three weeks after surgery, the only
operative death in the series. Seven patients received postoperative radiotherapy
because tumour removal was incomplete. In four there was subsequent tumour
recurrence necessitating a second operation; two of these had received radio-
therapy. The mean time from primary diagnosis to recurrence was 13 months,
range three to 33 months.
Neuropathology
Nine tumours (60%) were variously distributed within the spinal cord; six (40%)
were confined to the conus, cauda equina and filum terminale. One tumour
stretched from the cervical region to the conus (Table 1).
TABLE I
Anatomical location of 15 spinal ependymomas diagnosed 1969-1988
Cervical ......... 1
Thoraco -lumbar ... 3
Lumbar ......... 4
Cervical to conus ... 1
Conus ........... 2
Cauda equina ...... 3
Filum terminale .... 1
Routine haematoxylin and eosin staining was sufficient to confirm the diagnosis
in most cases, which were well differentiated with regular features. Immunohisto-
chemicalstaining forglial fibrillaryacidicprotein (GFAP), andelectron microscopy
were used to confirm the ependymal natureofthe poorly differentiated examples.
Histologically, most were well differentiated with a regular cellular pattern and
cytological features indicative of low malignant potential. The tumours were grad-
ed according to the World Health Organisation system.' This grading correlated
well with survival times. Of the two tumours classified as Grade III, one survived
2 -5 years. One very poorly differentiated tumour was assigned to Grade IV, and
came closest to the concept of a primitive neuroectodermal tumour (PNET)
(Table 11).
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TABLE II
WHO classification: correlation with survival
Grade No ofpatients Outcome Survival (years)
4 All alive 2 5-17-0
11 8 1 dead* 2-5 - 17-5
111 2 1dead** 1 5- 2 5
IV/PNET 1 1 dead postoperative death at 3 weeks
*Death unrelated to tumour.
* *Death related to tumour.
All of those patients whose tumour was classified histologically as Grade I were
alive and well on 31 December 1988. One with a Grade 11 tumour had died three
years after surgery from an unrelated cause (confirmed by autopsy). In addition to
the postoperative death one other patient with a Grade III tumour had died one
and a half years after treatment.
DISCUSSION
The incidence of spinal ependymomas as a percentage of all ependymomas
during the 20 years ofthis study was 18%, which represents the incidence of this
condition in the population in Northern Ireland. Four patients were diagnosed in
the first decade and eleven in the second which suggests a rising frequency
although the numbers are small. In a national survey from Norway, Mork and
Loken2 reported that spinal tumours represented 53% of all ependymomas,
llgren et al3 reported a proportion of 41 % from Oxford, and Barone and Elvidge4
from Montreal found 37%. In common with other studies,2 3,4 5 we found that
children rarely developed spinal ependymomas and that the mean age at the time
of diagnosis was 33 years. The male: female ratio of 1 5: 1 is comparable with
that found in other series.6
Predictably, most patients presented with back pain, usually in the lumbar region,
together with lower limb weakness and a vague sensory loss below the level ofthe
tumour. Because of the slow growth of the tumour, delays in making a diagnosis
were common, as long as 12 years. Cooper and Epstein7 record a mean duration
ofsymptoms ofependymoma of8 3 years, and compare this with the duration of
symptoms of intramedullary astrocytoma which range from 15 years for Grade I
tumours, 10 years for Grade I1, to only 0
-8 years for Grade III/IV tumours.
Spinal ependymomas are most commonly found in the region of the conus
medullaris or the cauda equina. They are often quite large when first discovered
and can extend over several neural segments. Cooper and Epstein7 found the
mean length as 4*7 segments. In our group, 40% were located in the region of
the cauda equina. Mork and Loken2 found 53% ofthe tumours in the spinal cord
and 45% adjacent to the cauda equina. In none ofour patients wasthere a sign of
another primary tumour in the posterior cranial fossa, so that none was the result
of seeding to the spine from a tumour at a higher level in the neural axis.
Ependymomas are almost always well circumscribed and demarcated. In the
spinal cord they are usually well defined, elongated intramedullary masses that
can often be shelled out at surgery. However, the ependymal cells are embryo-
logical derivatives of primitive neuroectodermal cells and occasionally the
tumours assume this very malignant form.
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Survival and histological grading correlated very well. Ofthe three deaths two can
be related to tumour, one of these being Grade IV (primitive neuroectodermal
tumour) who died three weeks postoperatively. The second patient died from a
Grade III tumour 1 * 5 years after operation. Those whose tumours were graded I
or II had a mean survival time of six years, with three long term survivors, 13 *O to
17 5 years. Ninety percent of all our patients were alive at least two and a half
years after the diagnosis was made.
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